A common coding variant in CASP8 is associated with breast cancer risk
Angela Cox, Jonathan Beesley(QIMR Berghofer Medical Research Institute), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Nichola Johnson(Institute of Cancer Research), Hiltrud Brauch(German Cancer Research Center), Serena Scollen(Genomics (United Kingdom)), Peter Schürmann(Hannover Re (Germany)), Natalia Bogdanova(Medizinische Hochschule Hannover), Graham G. Giles(The University of Melbourne), Jenny Chang‐Claude(Universität Hamburg), Beata Pepłońska, Thilo Dörk(Hannover Re (Germany)), Angela Risch(German Cancer Research Center), Sabapathy P. Balasubramanian(Sheffield Teaching Hospitals NHS Foundation Trust), Karen A. Pooley(University of Cambridge), Caroline Baynes(University of Cambridge), Alison M. Dunning(University of Cambridge), David J. Hughes(University College Dublin), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Suleeporn Sangrajrang(National Cancer Institute of Thailand), Michael R. Stratton(Wellcome Sanger Institute), Heli Nevanlinna(University of Helsinki), Christina Justenhoven(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Silke Kropp(German Cancer Research Center), Carl Blomqvist(University of Helsinki), Malcolm Reed(Yorkshire Cancer Research), Diana Torres(German Cancer Research Center), Louise A. Brinton(National Cancer Institute), Olivia Fletcher(Breast Cancer Care), Kirsimari Aaltonen(University of Helsinki), Ute Hamann(German Cancer Research Center), C. K. Axelsson(University of Copenhagen), Rainer Fagerholm(358 (Finland)), Stig E. Bojesen(University of Copenhagen), Montserrat García‐Closas(Institute of Cancer Research), Børge G. Nordestgaard(Gentofte Hospital), Melissa C. Southey(The University of Melbourne), Nazneen Rahman(Institute of Cancer Research), Stephen J. Chanock(National Cancer Institute), Shan Wang‐Gohrke(Universität Ulm), Bruce A.J. Ponder(University of Cambridge), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Jolanta Lissowska, John L. Hopper(The University of Melbourne), Sheila Seal(Institute of Cancer Research), Margaret McCredie(University of Otago), Lorna J. Gibson(London School of Hygiene & Tropical Medicine), Fabrice Odefrey(Institute of Biomedical Sciences, Academia Sinica), Anthony Renwick(Institute of Cancer Research), Paul Brennan(Centre international de recherche sur le cancer)
Cited by 612
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
The cancer genome
|Nature|2009|3.5k